|
ZNF776 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.360800E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.177800E-01 |
| Normal-vs-Stage2 |
2.144600E-01 |
| Normal-vs-Stage3 |
3.60970000000682E-05 |
| Normal-vs-Stage4 |
1.69215999999972E-05 |
| Stage1-vs-Stage2 |
1.647810E-01 |
| Stage1-vs-Stage3 |
3.51400000000446E-05 |
| Stage1-vs-Stage4 |
2.30069999999083E-05 |
| Stage2-vs-Stage3 |
1.249800E-01 |
| Stage2-vs-Stage4 |
7.664000E-02 |
| Stage3-vs-Stage4 |
5.911400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.110300E-02 |
| Normal-vs-AfricanAmerican |
5.319900E-02 |
| Normal-vs-Asian |
7.528600E-01 |
| Caucasian-vs-AfricanAmerican |
5.108800E-01 |
| Caucasian-vs-Asian |
3.656200E-01 |
| AfricanAmerican-vs-Asian |
2.829800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.157940E-03 |
| Normal-vs-Female |
4.365200E-01 |
| Male-vs-Female |
2.803800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.570000E-01 |
| Normal-vs-Age(41-60Yrs) |
2.972200E-01 |
| Normal-vs-Age(61-80Yrs) |
9.227000E-04 |
| Normal-vs-Age(81-100Yrs) |
7.451500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.766400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.137000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.719200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.914200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.073400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.953400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.968450E-02 |
| Normal-vs-Grade 2 |
4.241200E-01 |
| Normal-vs-Grade 3 |
8.18590000000174E-05 |
| Normal-vs-Grade 4 |
1.13880016527901E-10 |
| Grade 1-vs-Grade 2 |
9.220200E-02 |
| Grade 1-vs-Grade 3 |
2.358000E-04 |
| Grade 1-vs-Grade 4 |
1.02110000010924E-07 |
| Grade 2-vs-Grade 3 |
3.10759999999632E-06 |
| Grade 2-vs-Grade 4 |
6.98208157956515E-12 |
| Grade 3-vs-Grade 4 |
2.952700E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.147800E-02 |
| Normal-vs-ccB subtype |
2.3753999999987E-05 |
| ccA subtype-vs-ccB subtype |
2.36120001328999E-09 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.970200E-02 |
| Normal-vs-N1 |
2.388000E-02 |
| N0-vs-N1 |
9.749500E-02 |
|
|
